Advertisement
Home Tags Kids: Misc.

Tag: Kids: Misc.

The rate of opioid addiction among Americans age 25 and under rose nearly six-fold from 2001 to 2014

Medications Underutilized for Treating Youth Opioid Abuse

Few young people aged 13 to 25 receiving buprenorphine or naltrexone
Proprotein convertase subtilisin/kexin type 9 is increased in young females and youth with type 1 diabetes

PCSK9 Increased in Females, Youth With Type 1 Diabetes

Among youth with T1DM, PCSK9 linked to HbA1c, triglycerides, cholesterol, LDL cholesterol, ApoB
In prepubertal

Metformin Tied to Decreased BMI z Score in Prepubertal Children

Notable increments also seen in quantitative insulin sensitivity check index, adiponectin-leptin ratio
The rate of abdominal radiograph use can be reduced in the pediatric emergency department setting with use of rational subgrouping and stratification on statistical process control charts

Rate of X-Ray Can Be Reduced for Constipation in Pediatric ER

Rational subgrouping, stratification on statistical process control charts can cut abdominal radiographs
For children undergoing lower abdominal surgery

Intra-Op Liberal Fluid Therapy Effectively Cuts Post-Op Nausea

Liberal intraoperative fluid therapy linked to lower incidence of post-op nausea, vomiting in children
In a report published online June 5 in the Journal of Clinical Pharmacology

Researchers Target Zolmitriptan Dosing for Pediatric Migraine

Study supports body-weight dosing of 5.0 mg and 2.5 mg for children >50 kg and <50 kg, respectively
Children with type 1 diabetes often have comorbid celiac disease

Comorbid Celiac Disease Common Among Youth With T1DM

Prevalence of celiac disease varied from 1.9 to 7.7 percent among children in U.S. and Australia

May 2017 Briefing – Pediatrics

Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for May 2017. This roundup includes the latest...
For patients with food allergy

Quality of Life May Drop for Some During Oral Immunotherapy

Patients with better QOL at baseline, might deteriorate after therapy
Cannabidiol can reduce seizure frequency in patients with Dravet Syndrome

Cannabidiol Promising for Seizures in Dravet Syndrome

Greater reduction in convulsive-seizure frequency, higher rates of adverse events than placebo